Dr. Yibin Kang is a native of Fujian Province in Southern China. Dr. Kang received his bachelor’s degree from the Department of Genetics at Fudan University in Shanghai in 1995. As a graduate student at Duke University, Dr. Kang studied the mechanism of retroviral gene regulation and cellular mRNA export with renowned virologist Bryan Cullen. After completing his graduate study at Duke in 2000, Dr. Kang joined the Memorial Sloan-Kettering Cancer Center as a postdoctoral fellow with Dr. Joan Massagué and pioneered a study on using functional genomic approach to elucidate mechanism of breast cancer metastasis. Dr. Kang joined the faculty of Princeton University as an Assistant Professor of Molecular Biology in the fall of 2004 and was promoted to Associate Professor with tenure in 2010.
Dr. Kang’s research focuses on the molecular mechanisms of breast cancer metastasis, which is responsible for the large majority of cancer deaths. Dr. Kang's laboratory applies a multidisciplinary approach to analyze the molecular basis of cancer metastasis, combining molecular biology and genomics tools with animal models and advanced in vivo imaging technologies. Dr. Kang has published over 60 original articles in leading journals such as Cell, Cancer Cell, and Nature Medicine. Dr. Kang's outstanding achievements have been recognized by many prestigious awards, including an AIMM-ASBMR John Haddad Young Investigator Award, the Padget Foundation Young Investigator Award, and an American Cancer Society Scholar Award. He was also one of the five recipients of the 2006 Department of Defense Era of Hope Scholar Award, intended for exceptionally talented, early-career scientists who have demonstrated that they are the best and brightest in their field through exceptional creativity, vision, and productivity. Dr. Kang was elected to the Board of Directors of the Metastasis Research Society in 2008 and was selected as one of three leading metastasis researchers as Champalimaud Investigators by Champalimaud Foundation for long-term support in metastasis research. In 2010, Dr. Kang received the inaugural Oudang Distinguished Lectureship award of the Korean Pharmaceutical Society which recognizes scholars who have make a major impact on the pharmaceutical research and related areas of life sciences. In 2011, Dr. Kang received the Vilcek Prize for Creative Promise in Biomedical Sciences, a prestigious honor for foreign-born artists and scientists who have demonstrated exceptional creativity and originality in the early stages of their careers and have make a majority contribution to the American Society.
Dr. Kang is a Big Think Delphi Fellow.